2005

Nov 15, 2005
Guidant Appoints Board Chairman James M. Cornelius as Interim Chief Executive Officer

Ronald W. Dollens Retires after 11 Years as CEO; Special Shareholder Meeting Anticipated in January Indianapolis, Ind. - In a joint press release issued earlier today, Guidant Corporation (NYSE:...

Nov 15, 2005
Guidant Reports Excellent 12-Month Results from SPIRIT FIRST Everolimus Eluting Coronary Stent Clinical Trial

Results Demonstrate Sustained Benefit of the XIENCE V Everolimus Eluting Coronary Stent System Indianapolis, Ind., and Dallas, Texas - Guidant Corporation (NYSE: GDT) today announced 12-month...

Nov 10, 2005
Guidant Completes Enrollment in International Drug Eluting Stent Clinical Trial

Data from Study Will Support Launch of XIENCE V Coronary Stent System Outside the United States Indianapolis, Ind. and Brussels - Guidant Corporation (NYSE: GDT) today announced that the company...

Nov 9, 2005
Guidant Announces Publication of Enhanced Product Performance Report

Cardiac Rhythm Management Report Delivers Unprecedented Level of Information Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) announced today the easy availability of even more detailed...

Nov 8, 2005
Guidant Announces Fourth Quarter Dividend

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company''s board of directors declared a fourth quarter dividend of $0.10 per share on outstanding common stock. This...

Show 5102550100 per page
Top